Clinical Trial Update: Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 trial evaluating interleukin-2 and interferon for metastatic kidney cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Interferon (interferon)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Centre Leon Berard | Conditions: Kidney Cancer | Phase 3 | Status: COMPLETED